Cetirizine
| Cetirizine | |
|---|---|
| Salts [] | |
|---|---|
| Cetirizine dihydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 388.90 g/mol [1] |
| Appearance | Crystals from ethanol [1] |
| Melting point | 110-115°C [1] |
| Boiling point | 542.1 °C at 760 mmHg [1] |
| Solubility | 101 mg/L [1] |
| Predicted LogP | 1.7 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C21H25ClN2O3 |
| IUPAC name | 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid |
| SMILES | C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl |
| InChI | InChI=1S/C21H25ClN2O3/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26/h1-9,21H,10-16H2,(H,25,26) |
| InChIKey | ZKLPARSLTMPFCP-UHFFFAOYSA-N |
| CAS number | 83881-51-0 |
| UNII | YO7261ME24 |
| PubChem CID | 2678 |
| Pharmacokinetics[] | |
|---|---|
| Onset | 20–42 minutes |
| Elimination half-life | Mean: 8.3 hours, Range: 6.5–10 hours[3] |
| Duration of action | ≥24 hours |
| Metabolism | Minimal (non-cytochrome P450-mediated) |
| Excretion | Urine: 70–85%, Feces: 10–13% |
| Routes of administration | By mouth |
Cetirizine (also known as Cetirizina, Virlix, Ziptek, Cetirizin, Cetirizinum, Cetryn, Setir, Hitrizin Film Tablet, Cetiderm or Reactine) is a substance of the 1-benzylpiperazine class.
Chemistry
Salts []
Stereochemistry []
Cetirizine is a racemic mixture of the enantiomers (optical activity ( + / - )).
Druglikeness
Lipinski's rule of five
Cetirizine matches Lipinski's rule of five.Pharmacology
ATC Classification
- respiratory system (R)
- antihistamines for systemic use (R06)
- antihistamines for systemic use (R06A)
- piperazine derivatives (R06AE)
- (R06AE07)
- cetirizine (R06AE07)
- sensory organs (S)
- ophthalmologicals (S01)
- decongestants and antiallergics (S01G)
- other antiallergics (S01GX)
- cetirizine (S01GX12)
MeSH Classification
Mechanism of action []
Cetirizine, a metabolite of _hydroxyzine_, is an antihistamine drug. Its main effects are achieved through selective inhibition of peripheral H1 receptors. The antihistamine activity of cetirizine has been shown in a variety of animal and human models. _In vivo_ and _ex vivo_ animal models have shown insignificant anticholinergic and antiserotonergic effects. In clinical studies, however, dry mouth was found to be more frequent with cetirizine than with a placebo. In vitro receptor binding studies have demonstrated no detectable affinity of cetirizine for histamine receptors other than the H1 receptors. Studies with radiolabeled cetirizine administration in the rat have demonstrated insignificant penetration into the brain. _Ex vivo_ studies in the mouse have shown that systemically administered cetirizine does not occupy cerebral H1 receptors significantly. [1]
Interactions []
Medical side effects []
239 side effects listed on drug labels in SIDER 4.1 (cetirizine).
- Headache
- Somnolence
- Nasopharyngitis
- Abdominal pain
- Gastrointestinal pain
- Asthenia
- Fatigue
- Body temperature increased
- Cough
- Bronchospasm
- Diarrhoea
- Dry mouth
- Otitis media
- Vomiting
- Epistaxis
- Pharyngitis
- Nausea
- Dyspepsia
- Weight increased
- Gastrointestinal disorder
- Dizziness
- Shock
- Syncope
- Loss of consciousness
- Aggression
- Aggressive reaction
- Amnesia
- Anaphylactic shock
- Haemolytic anaemia
- Angioedema
- Mental disorder
- Cholestasis
- Confusional state
- Feeling abnormal
- Malaise
- Drug eruption
- Fixed drug eruption
- Dysgeusia
- Dyskinesia
- Movement disorder
- Orofacial dyskinesia
- Dyspnoea
- Dysuria
- Oedema
- Enuresis
- Dermatitis
- Rash
- Glomerulonephritis
- Hallucination
- Cardiac disorder
- Hepatitis
- Hypersensitivity
- Hypotension
- Immune system disorder
- Myoclonus
- Nervous system disorder
- Palpitations
- Paraesthesia
- Pruritus
- Convulsion
- Completed suicide
- Tachycardia
- Thrombocytopenia
- Tremor
- Urticaria
- Vertigo
- Urinary retention
- Agitation
- Hyperkinesia
- Oculogyric crisis
- Oculogyration
- Hepatic function abnormal
- Gamma-glutamyltransferase increased
- Accommodation disorder
- Skin disorder
- Discomfort
- Ill-defined disorder
- Myalgia
- Musculoskeletal discomfort
- Arthralgia
- Increased appetite
- Memory impairment
- Extrapyramidal disorder
- Blood bilirubin increased
- Vision blurred
- Suicidal ideation
- Transaminases increased
- Visual impairment
- Abnormal vision
- Stillbirth
- Blood alkaline phosphatase increased
- Insomnia
- Eye disorder
- Congenital eye disorder
- Urethral disorder
- Urinary tract disorder
- Alopecia
- Decreased appetite
- Anxiety
- Arrhythmia
- Arthritis
- Ataxia
- Back pain
- Bone disorder
- Bronchitis
- Chest pain
- Infection
- Conjunctivitis
- Constipation
- Cystitis
- Bladder pain
- Cystitis noninfective
- Deafness
- Libido decreased
- Disturbance in sexual arousal
- Dehydration
- Dental caries
- Tooth caries aggravated NOS
- Depersonalisation
- Diabetes mellitus
- Dysmenorrhoea
- Ear pain
- Eczema
- Eructation
- Eye haemorrhage
- Flatulence
- Flushing
- Multiple fractures
- Fracture
- Furuncle
- Gastritis
- Glaucoma
- Cardiac failure
- Haematuria
- Haemorrhoids
- Herpes simplex
- Hyperaesthesia
- Hypertension
- Hypertrichosis
- Hyperventilation
- Hypoaesthesia
- Irritability
- Jaundice
- Arthropathy
- Osteoarthritis
- Muscle spasms
- Vaginal discharge
- Melaena
- Menorrhagia
- Menstrual disorder
- Metrorrhagia
- Hypertonia
- Fungal infection
- Myelitis
- Nasal polyps
- Nervousness
- Tension
- Nightmare
- Pain
- Pallor
- Pneumonia
- Polyuria
- Urine output increased
- Purpura
- Vascular purpura
- Rhinitis
- Scotoma
- Seborrhoeic dermatitis
- Salivary hypersecretion
- Sinusitis
- Skin mass
- Speech disorder
- Stomatitis
- Mouth ulceration
- Thirst
- Thyroid disorder
- Tinnitus
- Tongue disorder
- Tongue oedema
- Unintended pregnancy
- Upper respiratory tract infection
- Pollakiuria
- Urinary incontinence
- Urinary tract infection
- Vaginal inflammation
- Vaginal infection
- Viral infection
- Xerophthalmia
- Mood swings
- Affect lability
- Oedema peripheral
- Leg edema
- Migraine
- Periorbital oedema
- Application site reaction
- Tongue discolouration
- Generalised oedema
- Fluid retention
- Impaired healing
- Injection site inflammation
- Injury
- Muscular weakness
- Eye pain
- Dry skin
- Tendon disorder
- Photosensitivity reaction
- Muscle twitching
- Thinking abnormal
- Mental disability
- Cerebration impaired
- Rash erythematous
- Euphoric mood
- Disturbance in attention
- Ototoxicity
- Sputum increased
- Increased bronchial secretion
- Urine abnormality
- Urine analysis abnormal
- Dermatitis bullous
- Urticaria chronic
- Rectal haemorrhage
- Abdominal distension
- Rash maculo-papular
- Chills
- Blindness
- Lymphadenopathy
- Coordination abnormal
- Paralysis
- Face oedema
- Breast pain
- Menopausal symptoms
- Hot flush
- Hyperhidrosis
- Sleep disorder
- Hyperkeratosis
- Rhinitis seasonal
- Parosmia
- Dysphonia
- Ageusia
Indications
- Chronic spontaneous urticaria
- Conjunctivitis
- Conjunctivitis allergic
- Insect bite NOS
- Lacrimation
- Nasal congestion
- Perennial allergic rhinitis
- Postnasal drip
- Pruritus
- Redness
- Rhinitis allergic
- Rhinorrhoea
- Seasonal allergy
- Sneezing
- Urticaria
- Urticaria chronic
Subjective effects []
| 0xea / Cetirizine [] | |
|---|---|
Routes:
| |
| ninerik / Cetirizine [] | |
|---|---|
Routes:
| |
Legal status []
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 2678, Cetirizine. Accessed November 22, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/2678
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Cetirizine. UNII: YO7261ME24. Global Substance Registration System. Accessed November 22, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/YO7261ME24
Simons FE. Comparative pharmacology of H1 antihistamines: clinical relevance. The American Journal of Medicine. December 2002; 113(Suppl 9A):38S–46S. PMID 12517581. https://doi.org/10.1016/s0002-9343(02)01436-5
Reactine Product information. Health Canada. 24 January 2007. https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=46803
Reactine Product information. Health Canada. 4 August 1997. https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=11590
Zyrtec Product information. Health Canada. 5 July 2001. https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=43974
Zyrtec Allergy- cetirizine hydrochloride tablet, film coated. DailyMed. 11 February 2025. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b165db38-b302-4220-8627-77cb07bb078c
Quzyttir- cetirizine hydrochloride injection. DailyMed. 25 October 2022. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f33e859d-ebc9-4d4f-a57d-204c48760d20
Zerviate- cetirizine solution/ drops. DailyMed. 9 October 2023. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3e6fecc1-df71-4c01-a654-f55635617a7f
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 17:13:51 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 17:13:47 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 17:13:47 |
| gsrs | ok | 2026-11-20 17:13:48 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0005032) | 2026-11-20 17:13:47 |
| kegg | ok | 2026-11-20 17:13:49 |
| pubchem | ok | 2026-11-20 17:13:45 |
| missing (no r/tripreports posts mention it) | 2026-11-20 17:13:47 | |
| sider | ok | 2026-11-20 17:13:47 |
| structure | ok | 2026-11-20 17:13:47 |
| wikipedia | ok | 2026-11-20 17:13:47 |